DOCE Director Michael Schwartz, MD, Featured in UW Medicine Magazine

Dr. Michael Schwartz’ research has been featured in the current issue of UW Medicine Magazine. The article, entitled “Diabetes & Obesity via the Brain” focuses on the Schwartz Laboratory’s use of optogentics to understand the neurocircuitry activated in diabetes with the goal to develop new opportunities to treat or prevent the disease. DOCE researchers Gregory Morton, PhD and Thomas Meek, PhD are also featured in the article. Click here to view the full article. Dr. Schwartz is the RH Williams Endowed Chair in Medicine, Professor of Medicine, Division of Metabolism, Endocrinology and Nutrition.

 

DOCE Researcher Christiane Hampe, PhD, Receives T1D Exchange Biobank Pilot Award

Dr. Christiane Hampe has received a one year pilot research award through the T1D Exchange Biobank Operations Center at the Benaroya Research Institute (BRI) for her project entitled “GAD65Ab: Connecting Type 1 Diabetes and Epilepsy”.  This proposal focuses on the investigation of GAD65Ab in T1D-associated epilepsy. The T1D Exchange Biobank Operations Center at BRI was established in 2013 through a grant from The Liona M. and Harry B. Helmsley Charitable Trust. Dr. Hampe is a Research Associate Professor of Medicine in the Division of Metabolism, Endocrinology and Nutrition.

 

DOCE Researcher Christiane Hampe, PhD, Receives National Ataxia Foundation Award

Dr. Christiane Hampe has received an award from the National Ataxia Foundation for her project entitled Glutamate Decarboxylase in Cerebellar Ataxia. This one year award investigates the involvement of GAD65 in cerebellar ataxias to better understand the underlying pathogenesis and to design targeted treatment options. Dr. Hampe is a Research Associate Professor of Medicine in the Division of Metabolism, Endocrinology and Nutrition.

 

DOCE Director Michael Schwartz, MD, Cross-published in Endocrine Society Journals

Dr. Michael Schwartz is author of a recent editorial entitled Can the History of Modern Endocrinology Shape the Future of Obesity? which has been cross-published in all three Endocrine Society journals: EndocrinologyMolecular Endocrinology and the Journal of Clinical Endocrinology and Metabolism.  Dr. Schwartz is the RH Williams Endowed Chair in Medicine, Professor, Division of Metabolism, Endocrinology and Nutrition.

 

The Diabetes Research Center (DRC) is soliciting applications for the Pilot and Feasibility, McAbee Fellowship and Stroum Graduate Fellowship Awards.

Letters of Intent are due by January 5, 2015 and the deadline for applications is February 23, 2015.

Letters of intent must be submitted using the online form. (Please be patient with the DRC website as some content can be slow to load).

The funding announcements are provided below and can also be found at the DRC website: https://depts.washington.edu/diabetes/currentfundingapplication

McAbee Fellowship 2015
P&F 2015
Stroum Fellowship 2015

DOCE Director Michael Schwartz, MD, recognized in European Journal of Clinical Investigation

Dr. Michael Schwartz has been recognized as one of the most highly influential biomedical researchers in a paper published in the European Journal of Clinical Investigation. The article entitled “A list of highly influential biomedical researchers, 1996-2011“, is based on Scopus citation data and contains a list of 400 core biomedical researchers. Dr. Schwartz is the RH Williams Endowed Chair in Medicine and Professor of Medicine, Division of Metabolism, Endocrinology and Nutrition.

DOCE researcher Christiane Hampe, PhD, published in Diabetic Medicine

Dr. Christiane Hampe is co-author on the article “Antibodies to islet cell autoantigens, rotaviruses and/or enteroviruses in cord blood and healthy mothers in relation to the 2010–2011 winter viral seasons in Israel: a pilot study” published in Diabetic Medicine. The article focuses on research indicating prenatal exposure to viruses may cause type 1 diabetes and other autoimmune diseases in children. These findings were part of a recent interview with the senior author, Zvi Laron, in the Israeli leading newspaper Yediot Ahronot. The Tel Aviv University summarized the Hebrew interview in English (click here for article). Dr. Hampe is a Research Associate Professor of Medicine, Division of Metabolism, Endocrinology and Nutrition.

 

DOCE Director Michael Schwartz, MD, Featured in ASCI Interview

Dr. Michael Schwartz is featured in an interview by the American Society for Clinical Investigation (ASCI), published on September 10, 2014. The focus of The ASCI Interviews series is to provide the American public with a better understanding of how federal taxes support medical advances. Click here for the full transcript of the interview. Dr. Schwartz is the RH Williams Endowed Chair, Director of the Diabetes and Obesity Center of Excellence and a Professor of Medicine in the Division of Metabolism, Endocrinology and Nutrition.

DOCE Researcher Joshua Thaler, MD, PhD, Receives NIH R03

Dr. Joshua Thaler has been awarded an NIH R03 for his project entitled “Glial-neuronal metabolic coupling in obesity”. This proposal focuses on lactate signaling between hypothalamic astrocytes and neurons. The data obtained from these investigations will form the basis of a new line of research centered on glial-neuronal metabolic coupling as a novel obesity target. Dr. Thaler is an Assistant Professor of Medicine, Division of Metabolism, Endocrinology and Nutrition.

DOCE Director Michael Schwartz, MD, Receives NIH R01

Dr. Michael Schwartz has been awarded a 4-year NIH R01 for his project ” Novel Brain Mechanisms Controlling Glucose Homeostasis”. This project is based upon recently published evidence from the Schwartz Laboratory that the brain can rapidly, potently and selectively increase insulin-independent glucose lowering. The overarching goals are to employ state-of-the-art methods of metabolic analysis in defined mouse models to 1) more clarify how these centrally mediated effects are mediated and identify the humoral signals that activate them, 2) delineate peripheral mechanisms of glucose lowering, and 3) establish their physiological relevance. Dr. Schwartz is the RH Williams Endowed Chair in Medicine, Division of Metabolism, Endocrinology and Nutrition.